Mindray Expands Cardiac Biomarker Portfolio with New Assays
Mindray introduced new cardiac biomarkers aimed at diversifying its portfolio for cardiovascular disease diagnosis and management.
Read MorePosted by Andy Lundin | Oct 26, 2023 | Cardiovascular |
Mindray introduced new cardiac biomarkers aimed at diversifying its portfolio for cardiovascular disease diagnosis and management.
Read MorePosted by Melissa Mayer | Sep 8, 2018 | Cerebrovascular, Diagnostic Technologies, Stroke |
Glycated serum protein, lipoprotein (a), and cystatin c Microtip Partnership assays are now available for use on the Vitros 4600 clinical chemistry system and the Vitros 5600 integrated chemistry and immunoassay system.
Read MorePosted by Clinical Lab Products | Sep 20, 2010 | Miscellaneous |
Roche Diagnostics announced that it has introduced a complete battery of STAT immunoassays for cardiac biomarker testing on the cobas 6000 analyzer series, an integrated system designed for diagnostic labs with medium testing volumes.
Read MorePosted by Andy Lundin | Oct 15, 2024 | Cardiovascular |
The Atellica IM Troponin I test received clearance for predicting cardiac events after initial symptoms of acute coronary syndrome.
Read MorePosted by Andy Lundin | Jun 27, 2024 | Cardiovascular |
Siemens Healthineers introduced the NT-proBNPII assay to its Atellica Solution, enhancing rapid diagnostic capabilities for heart failure.
Read More